Correction: Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and Clinical Studies(Pharmaceutics, (2022), 14, (833), 10.3390/pharmaceutics14040833)

2Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Error in Table In the original publication [1], there was a mistake in Table 3 as published. The mistakes pertained to the manufacturer information listed in the rows corresponding to the Optison® and SonoVue®/Lumason® microbubbles. We acknowledge that some manufacturer information was outdated, and no longer currently accurate, e.g., the mean bubble diameters and concentrations. In addition, some information was accidentally misclassified between the two microbubbles, e.g., the gas core and shell composition. The corrected Table 3 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Cite

CITATION STYLE

APA

Gandhi, K., Barzegar-Fallah, A., Banstola, A., Rizwan, S. B., & Reynolds, J. N. J. (2023, January 1). Correction: Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and Clinical Studies(Pharmaceutics, (2022), 14, (833), 10.3390/pharmaceutics14040833). Pharmaceutics. MDPI. https://doi.org/10.3390/pharmaceutics15010005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free